Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Intraventricular Methotrexate With Systemic Topotecan and Cyclophosphamide in Children With Recurrent or Progressive Malignant Brain Tumors

NCT02684071 is registered in ClinicalTrials.gov with Nicklaus Children's Hospital f/k/a Miami Children's Hospital as lead sponsor.

NCT NCT02684071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02684071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Intraventricular Methotrexate With Systemic Topotecan and Cyclophosphamide in Children With Recurrent or Progressive Malignant Brain Tumors
Lead sponsor
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2016
Completion date
December 9, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood atypical teratoid/rhabdoid tumor, embryonal tumor with abundant neuropil and true rosettes, metastatic malignant neoplasm to the leptomeninges, recurrent childhood ependymoma, recurrent childhood medulloblastoma